Stockreport

Imara to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

IMARA Inc.  (IMRA) 
PDF BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel thera [Read more]